EU Manufacturer ๐Ÿ‡ฎ๐Ÿ‡น Italy Active

Drugs Minerals and Generics Italia S.r.l.

SRN: IT-MF-000024945 ยท Via Laurentina Km 26,700, 00071 Pomezia , Italy
Basic UDI-DIs
117
Total Devices
117
On Market
117
Off Market
0
Certificates
27
Valid
0
Expiring < 6mo
0
Countries
22

Basic Information

Address
Via Laurentina Km 26,700, 00071 Pomezia , Italy

Regulatory Overview

Regulation
Loading...
Eu Mdd 117
Classification
Loading...
Eu Md Class 2a 84
Eu Md Class 2b 33

Certificate Health

Total
27
Valid
0
Expiring < 6mo
0
Expired / Withdrawn
27
Certificates by Expiry Year
Loading...
Type Number Expiry Date Status
MDD Annex II (excluding section 4) QCT-0081-18-17-18 Mar 21, 2023
MDD Annex II (excluding section 4) Lettera approvazione ISS del 26/01/2022 Prot. 3131/ON0373.ON12 MCE 95/22 Mar 21, 2023
MDD Annex II (excluding section 4) QCT-0090-18-03-18 Jun 24, 2023
MDD Annex II (excluding section 4) Lettera approvazione ISS del 04/01/2024 Prot. 216/ON-ISS.12.00 MCE 4/24 Jun 24, 2023
MDD Annex II (excluding section 4) QCT-0090-18- 06-18 Jun 24, 2023
MDD Annex II (excluding section 4) QCT-0090-18-07-18 Jun 24, 2023
MDD Annex II (excluding section 4) EPT 0477.MDD.20/3837 Mar 24, 2024
MDD Annex II (excluding section 4) EPT 0477.MDD.20/3836 Mar 24, 2024
MDD Annex II (excluding section 4) EPT 0477.MDD.20/3839 Mar 24, 2024
MDD Annex II (excluding section 4) EPT 0477.MDD.20/3838 Mar 24, 2024
MDD Annex II (excluding section 4) EPT 0477.MDD.20/3838 Mar 24, 2024
MDD Annex II (excluding section 4) EPT 0477.MDD.21/4232 Mar 24, 2024
MDD Annex II (excluding section 4) EPT 0477.MDD.20/3887 Mar 24, 2024
MDD Annex II (excluding section 4) EPT 0477.MDD.20/3888 Mar 24, 2024
MDD Annex V QPZ-1911-19-13-19 Apr 14, 2024
MDD Annex V QPZ-1911-19-25-20 Apr 14, 2024
MDD Annex V QPZ-1911-19-12-19 Apr 14, 2024
MDD Annex V 05/09/2023 โ€“ Prot. 40029 โ€“ ON-ISS.12.00 Apr 14, 2024
MDD Annex V QPZ-1911-19-22-20 Apr 14, 2024
MDD Annex V 26/06/2023 โ€“ Prot. 30262โ€“ ON-ISS.12.00 Apr 14, 2024
MDD Annex V QPZ-1911-19-09-19 Apr 14, 2024
MDD Annex V QPZ-1911-19-01-19 Apr 14, 2024
MDD Annex V QPZ-1911-19-23-20 Apr 14, 2024
MDD Annex V 26/06/2023 โ€“ Prot. 30261โ€“ ON-ISS.12.00 Apr 14, 2024
MDD Annex V QPZ-1911-19-08-19 Apr 14, 2024
MDD Annex V QPZ-1911-19 Apr 14, 2024
MDD Annex V QPZ-1911-19-06-19 Apr 14, 2024

Market Presence

Devices from this manufacturer are available in 22 countries across Europe.

๐Ÿ‡ง๐Ÿ‡ช Belgium ๐Ÿ‡ง๐Ÿ‡ฌ Bulgaria ๐Ÿ‡จ๐Ÿ‡พ Cyprus ๐Ÿ‡จ๐Ÿ‡ฟ Czechia ๐Ÿ‡ฉ๐Ÿ‡ช Germany ๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark ๐Ÿ‡ช๐Ÿ‡ช Estonia ๐Ÿ‡ฌ๐Ÿ‡ท Greece ๐Ÿ‡ช๐Ÿ‡ธ Spain ๐Ÿ‡ซ๐Ÿ‡ฎ Finland ๐Ÿ‡ซ๐Ÿ‡ท France ๐Ÿ‡ญ๐Ÿ‡บ Hungary ๐Ÿ‡ฎ๐Ÿ‡น Italy ๐Ÿ‡ฑ๐Ÿ‡น Lithuania ๐Ÿ‡ฑ๐Ÿ‡ป Latvia ๐Ÿ‡ฒ๐Ÿ‡น Malta ๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands ๐Ÿ‡ต๐Ÿ‡ฑ Poland ๐Ÿ‡ต๐Ÿ‡น Portugal ๐Ÿ‡ท๐Ÿ‡ด Romania ๐Ÿ‡ธ๐Ÿ‡ฐ Slovakia ๐Ÿ‡น๐Ÿ‡ท Tรผrkiye

Device Portfolio

Name
A-VITA PLUS (Gocce Nasali)
A-VITA PLUS (Unguento Nasale)
Bloxinus
Bloxinus
Bloxinus
Bloxinus
Bloxoto
Bloxoto
Bloxrhume
Bloxwash
Cerucalm
Cue
Cue
Cue
Cue
Cue
Cue
Cue
Cue
Cue
Cue
Cue
Gastrocure Baby
Gastrocure Basis
Gastrokids
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss
Gastrotuss Baby
Gastrotuss Baby
Gastrotuss Baby
Gastrotuss Baby
Gastrotuss Baby
Gastrotuss Baby
Gastrotuss Baby
Gastrotuss Baby